Our data indicated that iMDK application could globally eliminate IFN-γ-induced MDK, reverse IFN-γ-induced EMT activation, and ultimately abrogate IFN-γ-triggered cancer migration and invasion in all examined cancer cell lines. The gene discussed is IFNG; the disease is cancer.